On December 22, 2017, Patillo J. of the Ontario Super Court of Justice held that Apotex was entitled to $11,303,131.80, plus pre-judgment interest, for losses flowing from delays in the US Food and ...

Many biosimilar applicants have resorted to inter partes review (IPR) proceedings to challenge innovator patents as an alternative forum to district court litigation under the BPCIA. For those ...

Even amid a pandemic, the Department of Justice isn’t giving up on its years-long generics price-fixing probe. Following several other guilty pleas and company settlements, federal authorities have ...

Back story: BMS struck a bonkers deal with Apotex in which Apotex would buy a license to produce BMS's blockbuster blood-thinner. The agreement had a catch -- if the feds didn't like it, then Apotex ...

Federal regulators have raised another red flag about the quality of generic drugs, sending a warning letter to a leading maker about manufacturing violations. In the letter, posted on the Food and ...

Apotex has recalled all its Metformin Hydrochloride Extended-Release Tablets 500 mg in the United States for too much of carcinogen NDMA, the same “impurity” that got all the Zantac yanked earlier ...

A generic form of the Bristol-Myers Squibb anticoagulant Plavix saw launch by Canadian generic drug maker Apotex, delivering a big blow to BMS. The launch came today, shortly after BMS noted in a ...

TORONTO, March 20, 2020 /CNW/ - Apotex, Canada's largest pharmaceutical company, announced today that it is donating Hydroxychloroquine to accelerate a study examining if it prevents infection of ...

TORONTO, May 20, 2025 /CNW/ - Apotex Inc. ("Apotex"), the Canadian-based global health company, today published its 2024 Sustainability Report, showcasing its ongoing commitment to sustainable, ...

Apotex, the largest generics drugmaker in Canada, has agreed to merge its Australian business with that of India’s Strides Shasun. The combined operations are expected to create the largest generic ...

TORONTO, July 2, 2025 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has approved Aflivu™ (aflibercept), a ...